TRUL:CNSX-Trulieve Cannabis Corp (CAD)

COMMON STOCK | Drug Manufacturers-Specialty & Generic | CNSX

Last Closing Price

CAD 12.35

Change

+0.53 (+4.48)%

Market Cap

CAD 3.23B

Volume

0.17M

Avg Analyst Target

CAD 31.20 (+152.63%)

Avg User Target

CAD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


TRUL Stock Forecast & Price:
Based on the Trulieve Cannabis Corp stock forecasts from 4 analysts, the average analyst target price for Trulieve Cannabis Corp is CAD 31.20 over the next 12 months. Trulieve Cannabis Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Trulieve Cannabis Corp is Neutral, which is based on 7 positive signals and 6 negative signals. At the last closing, Trulieve Cannabis Corp’s stock price was CAD 12.35. Trulieve Cannabis Corp’s stock price has changed by +3.52% over the past week, -35.10% over the past month and -65.36% over the last year.

About Trulieve Cannabis Corp (TRUL:CA:CNSX)

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. It cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. The company produces ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-10-04 )

Largest Industry Peers for Drug Manufacturers-Specialty & Generic

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CURA:CA Curaleaf Holdings Inc

-0.15 (-2.21%)

CAD4.76B N/A 19.54
GTII:CA Green Thumb Industries Inc

N/A

CAD3.31B 24.14 9.61
HARV:CA Harvest Health & Recreation In..

N/A

CAD1.65B N/A 122.88
CL:CA Cresco Labs Inc

-0.15 (-3.96%)

CAD1.09B N/A -13.09
CCHW:CA Columbia Care Inc

-0.10 (-5.56%)

CAD0.64B N/A -26.07
LHS:CA Liberty Health Sciences Inc

N/A

CAD0.51B 147.00 13.82
IAN:CA iAnthus Capital Holdings Inc

-0.01 (-8.33%)

CAD0.37B N/A -1.65
VREO:CA Goodness Growth Holdings, Inc

N/A

CAD0.37B N/A N/A
JUSH:CA Jushi Holdings Inc

+0.03 (+1.78%)

CAD0.36B N/A 5.93
MOVE:CA Clean Power Capital Corp

N/A

CAD0.35B N/A N/A

ETFs Containing TRUL:CA

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers-Specialty & Generic)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -62.47% 46% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -62.47% 46% F 38% F
Trailing 12 Months  
Capital Gain -66.73% 53% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -66.73% 53% F 40% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -21.65% 51% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -21.65% 51% F 33% F
Risk Return Profile  
Volatility (Standard Deviation) 28.45% 85% B 80% B-
Risk Adjusted Return -76.09% 25% F 20% F
Market Capitalization 3.23B 98% A+ 100% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Drug Manufacturers-Specialty & Generic)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 121.35 5% F 6% F
Price/Book Ratio 1.30 50% F 62% D-
Price / Cash Flow Ratio 250.23 1% F 1% F
EV/EBITDA 16.72 7% F 3% F
Management Effectiveness  
Return on Equity -3.46% 89% B+ 93% A
Return on Invested Capital 3.64% 87% B+ 82% B-
Return on Assets 6.52% 95% A 98% A+
Debt to Equity Ratio 21.87% 34% F 25% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 1.58 15% F 12% F
Short Percent 0.34% 10% F 11% F
Beta 1.36 46% F 45% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.